Corporate calendar for GH Research PLC (GHRS): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD).
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | $0.14 | $118M |
| 2026-09-14 | $-0.06 | $36M |
| 2026-09-14 | ||
| 2026-09-14 | $-0.62 | $29M |
| 2026-09-14 | $0.10 | $672M |
Price
| Price | $27.75 |
| Market Cap | $1.9B |
| Exchange | NASDAQ |
| Country | IE |
Related companies: ABUS · KURA · LENZ · NBTX · PROK · PVLA · RZLT
Explore sector: Healthcare · Biotechnology
More sections of GHRS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks